Organ Preservation Market - Emerging Industry Trends & Future Forecasts

The study involved four major activities in estimating the current size of the organ preservation market. Exhaustive secondary research was done to collect information on the market and its different subsegments. 

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. 

 The report "Organ Preservation Market by Solution (UW/Custodiol HTK/Perfadex), Technique (Static Cold Storage/Hypothermic Machine Perfusion/ Normothermic Machine Perfusion), Organ Type (Kidneys/Liver/Lungs/Heart), Region - Global Forecast to 2024", is projected to reach USD 284 million by 2024 from USD 207 million in 2019, at a CAGR of 6.5%. 

The growth of the organ preservation market is mainly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. 

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915

“By Solution, University of Wisconsin (UW) holds the largest market share.”

Based on the Solution, the segment is divided into UW, Custodial HTK, Perfadex and Other solutions (EuroCollins and Celsior). In 2019, the UW solution accounted for the highest share in 2019. The UW solution is used for the flushing and storage of kidneys, liver, and pancreas. It was the first intracellular preservation medium, considered the gold standard for organ preservation.

“By Organ type, Kidney holds the largest market share and lungs is expected to grow at the highest CAGR in the forecast period.”

Kidneys account for the largest market share in the organ segment. Renal transplantation is considered the treatment of choice for patients with end-stage renal disease (ESRD) or kidney failure, diabetes etc. are all cause for the growth of this segment. Lungs market is expected to grow at a faster rate in the period of 2019 to 2024. This is mainly due to the rising prevalence of COPD and other target diseases & disorders necessitating lung transplantation.

Key Questions Addressed by the Report:

# Which solution segment will dominate the organ preservation market in the future?
# Which technique segment will dominate the organ preservation market in the future?
# Emerging countries offer immense opportunities for the growth and adoption of organ preservation market; will this scenario continue in the coming five years?
# What are the upcoming products in the organ preservation market?

“The Asia Pacific to witness the highest growth during the forecast period.”

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2019–2024. The major factors driving the growth of the Asia Pacific market include favorable government initiatives, increased awareness in people and increased organ donations.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915

The prominent players in this market include Paragonix Technologies, XVIVO Perfusion, Dr. Franz Köhler Chemie GMBH, Essential Pharmaceuticals, TransMedics, Organix, 21st Century Medicine, Shanghai Genext Medical Technology and Bridge to Life Limited.

The growth of these players can be attributed to various product launches & approvals, acquisitions, agreements, partnerships, and collaborations to increase their shares in the organ preservation market.